Article citationsMore >>

Brown NJ, Snowden M, Griffin MR. Recurrent angiotensin-converting enzyme inhibitor--associated angioedema. JAMA. 1997; 278(3): 232.

has been cited by the following article:

Article

Acute Respiratory Failure Secondary to ACE Inhibitor–Induced Angioedema after Five Years of Lisinopril Therapy

1Department of Medicine, Heritage College of Osteopathic Medicine, Southern Ohio Medical Center, Ohio University, Portsmouth, Ohio, USA


American Journal of Medical Case Reports. 2020, Vol. 8 No. 1, 8-10
DOI: 10.12691/ajmcr-8-1-2
Copyright © 2019 Science and Education Publishing

Cite this paper:
Tariq Sharman, Jeffrey Song, Misam Zawit, Una Ijeoma-Nchinda. Acute Respiratory Failure Secondary to ACE Inhibitor–Induced Angioedema after Five Years of Lisinopril Therapy. American Journal of Medical Case Reports. 2020; 8(1):8-10. doi: 10.12691/ajmcr-8-1-2.

Correspondence to: Tariq  Sharman, Department of Medicine, Heritage College of Osteopathic Medicine, Southern Ohio Medical Center, Ohio University, Portsmouth, Ohio, USA. Email: tysharman@yahoo.com

Abstract

Angiotensin-converting enzyme (ACE) inhibitors are amongst the commonest prescribed medications in the United States and considered to be the leading causes of drug induced angioedema. High bradykinin levels stimulate vasodilation and increased vascular permeability of the post-capillary venules and allow for plasma extravasation into the submucosal tissue, leading to angioedema. Usually, the angioedema occurs within the first week of exposure to therapy, but cases occurring after years of stable ACE inhibitor usage are not uncommon. Here, we present a 43-year-old Caucasian female who developed acute respiratory failure requiring mechanical ventilation secondary to ACEi–induced angioedema after five years of Lisinopril usage. This case will help to increase physicians’ awareness that this potentially fatal complication can still occur after years of ACE inhibitor usage.

Keywords